Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNinety One Regulatory News (N91)

Share Price Information for Ninety One (N91)

Share Price is delayed by 15 minutes
Get Live Data
214.20    0.20 (0.09%)
Bid:
214.00
Ask:
214.20
Spread: 0.20 (0.093%)
Market Cap: £2.07b
N91 Live PriceLast checked at - London Stock Exchange

Intraday Ninety One Share Chart

Directorate Changes

4 Jun 2025 07:01

RNS Number : 2942L
Ninety One PLC
04 June 2025
 

Ninety One Limited Incorporated in the Republic of South Africa

Registration number 2019/526481/06

Date of registration: 18 October 2019JSE share code: NY1

ISIN: ZAE000282356

 

Ninety One plc Incorporated in England and Wales

Registration number 12245293

Date of registration: 4 October 2019LSE share code: N91

JSE share code: N91

ISIN: GB00BJHPLV88

LEI: 549300G0TJCT3K15ZG14

 

 

 

As part of the dual-listed companies' structure, Ninety One plc and Ninety One Limited notify both the LSE and the JSE of matters which are required to be disclosed under the Disclosure Guidance and Transparency Rules and Listing Rules of the FCA and/or the Listings Requirements of the JSE.

 

 

DIRECTOR RETIREMENT

 

Ninety One plc and Ninety One Limited (together "Ninety One" and "the Board") announce that Colin Keogh, independent non-executive director of Ninety One, has informed the Board that he will not be seeking re-election at the forthcoming Annual General Meetings ("AGM") on Wednesday, 23 July 2025, and will retire from Ninety One at the conclusion of that meeting.

 

The Board wishes to thank Colin for his contributions to Ninety One during a period of great change for the business and wishes him well with his future endeavours.

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

At the same time the Board is pleased to confirm the appointment of Mr Charles Harman as an independent non-executive director of the Board of Ninety One, with effect from 24 July 2025. Charles will be appointed to the Ninety One Audit and Risk Committee and the Ninety One Human Capital and Remuneration Committee at the same time.

 

Charles brings over thirty years of investment banking experience, leadership in capital markets, corporate finance, and risk oversight. His prior roles include Managing Director at Credit Suisse, Head of UK Investment Banking at J.P. Morgan Cazenove, and Chief Executive Officer of BXR Partners. He is currently the external Deputy Chair of Council of the University of Oxford. Charles will stand for election by Ninety One's shareholders at the Company's 2026 AGM.

 

The Board congratulates Charles on his appointment as a non-executive director of the Board and looks forward to working with him in the coming years.

 

CHANGES TO DIRECTOR APPOINTMENTS

 

With effect from 24 July 2025, Busisiwe Mabuza, who has served on the Board since November 2019, will be appointed as Senior Independent Director and Chair of the Ninety One Human Capital and Remuneration Committee. Khumo Shuenyane, who has served on the Board since August 2021, will replace Busisiwe Mabuza as Chair of the Ninety One Sustainability, Social and Ethics Committee.

 

This announcement has been made pursuant to the UK Listing Rule 6.4.6R and JSE Limited Listing Requirements paragraph 3.59

There are no further details required to be disclosed by Rule 6.4.8R of the UK Listing Rules.

 

4 June 2025

 

JSE Sponsor:

J.P. Morgan Equities South Africa Proprietary Limited

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSWFADEISEDM
Date   Source Headline
24th Aug 20232:00 pmRNSDirector/PDMR Shareholding
21st Aug 20232:00 pmRNSDirector/PDMR Shareholding
17th Aug 20234:00 pmRNSDirector/PDMR Shareholding
17th Aug 20232:00 pmRNSDirector/PDMR Shareholding
16th Aug 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
10th Aug 20234:00 pmRNSHolding(s) in Company
10th Aug 202312:00 pmRNSDirector/PDMR Shareholding
8th Aug 20234:00 pmRNSDirector/PDMR Shareholding
7th Aug 20231:00 pmRNSDirector/PDMR Shareholding
3rd Aug 20232:00 pmRNSDirector/PDMR Shareholding
3rd Aug 20232:00 pmRNSHolding(s) in Company
27th Jul 20231:00 pmRNSDirector/PDMR Shareholding
26th Jul 20234:30 pmRNSHolding(s) in Company
26th Jul 20234:30 pmRNSResult of AGM
17th Jul 202310:00 amRNSHolding(s) in Company
14th Jul 20237:00 amRNS1st Quarter Update
13th Jul 20231:00 pmRNSDirector/PDMR Shareholding
10th Jul 20232:00 pmRNSB-BBEE Act: Annual Compliance Report
10th Jul 20231:00 pmRNSDirector/PDMR Shareholding
29th Jun 20231:00 pmRNSDirector/PDMR Shareholding
28th Jun 20232:00 pmRNSDirector/PDMR Shareholding
23rd Jun 202312:00 pmRNSDealing In Securities by Employee Benefit Trusts
21st Jun 20231:00 pmRNSDealing In Securities by Employee Benefit Trusts
20th Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
19th Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
15th Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
14th Jun 20233:30 pmRNSAnnual Financial Report and Notice of AGM
14th Jun 20233:30 pmRNSDealing In Securities by Employee Benefit Trusts
13th Jun 20233:30 pmRNSDealing In Securities by Employee Benefit Trusts
12th Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
9th Jun 20234:00 pmRNSDealing In Securities by Employee Benefit Trusts
6th Jun 20233:00 pmRNSDirector/PDMR Shareholding
6th Jun 20233:00 pmRNSDealing In Securities by Employee Benefit Trusts
5th Jun 20233:00 pmRNSDealing In Securities by Employee Benefit Trusts
2nd Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
1st Jun 20234:00 pmRNSDirector/PDMR Shareholding
1st Jun 20234:00 pmRNSDealing in Securities by Employee Benefit Trust
1st Jun 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20231:00 pmRNSDirector/PDMR Shareholding
25th May 20231:00 pmRNSDirector/PDMR Shareholding
22nd May 20231:00 pmRNSDirector/PDMR Shareholding
19th May 20231:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSDirector/PDMR Shareholding
17th May 20237:00 amRNSFinal Results
28th Apr 202312:00 pmRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNS4th Quarter Update
27th Mar 20231:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20231:00 pmRNSDirector/PDMR Shareholding
20th Mar 20231:00 pmRNSDirector/PDMR Shareholding
20th Mar 20231:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.